AzTrials
AzTrials

Induction of Labor Affected Fetus / NewbornPhase 1NCT03658590

Dexamethasone and Induction of Delivery

A Phase 1 study testing Dexamethasone and Distilled Water in people with Induction of Labor Affected Fetus / Newborn, run by samar sayed el sayed at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the effect of intravenous injection of a single dose of dexamethasone in shortening the duration interval between initiation of labor induction and delivery of the fetus in primigravida full-term pregnancy. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
What is being tested?
Dexamethasone and Distilled Water
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
102 participants
Where
1 siteEgypt
Study dates
1 Jan 2018to 30 Jun 2018
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Primiparity
  • Singleton pregnancy
  • Gestational age i.e. 40 weeks or more by date or 1sttrimestric ultrasound.
  • Bishop score of 4 or greater.
  • Longitudinal lie.
  • Vertex presentation.
  • Intact membranes

Who cannot join

  • Refused consent
  • Malpresentation.
  • Multiple pregnancies.
  • Active phase of labour.
  • Rupture of membranes (ROM).
  • Cephalo-pelvic disproportion.
Show all 13Show fewer
  • Previous C-section or myomectomy operation.
  • Known contraindication or hypersensitivity to Dexamethasone.
  • Fetal distress.
  • IUFD
  • Current maternal disorder e.g. diabetes mellitus and pregnancy induced hypertension.
  • Over distended abdomen e.g. fetal macrosomia or polyhydramonus suggested by ultrasound.
  • Ante-partum hemorrhage e.g. placenta previa, accidental hemorrhage.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain Shams University

    Cairo

Other trials in Egypt

About this study

Official title: Dexamethasone Effect on Induction Delivery Interval at Term Randomized Controlled Trial

This study aims to evaluate the effect of intravenous injection of a single dose of dexamethasone in shortening the duration interval between initiation of labor induction and delivery of the fetus in primigravida full-term pregnancy.

Read the detailed description

Research hypothesis:

In full term primigravidae undergoing induction of labor, the use of a single dose of dexamethasone (8mg) intra-venously will help in shortening the duration interval between initiation of labor induction and delivery of the fetus.

Research question:

In full term primigravidae undergoing induction of labor, does the use of intra-venous dexamethasone play a role in shortening the duration interval between initiation of labor induction and delivery of the fetus?

Patients and Methods

Type of study:

Double blind randomized controlled trial.

Study settings:

Site: Ain Shams Maternity Hospital Study duration: 6 months

Study population:

One hundred and two pregnant women will be recruited in this study from women attending the emergency room department of obstetrics and gynecology at Ain Shams University.

Inclusion criteria:

Primiparity Singleton pregnancy Gestational age i.e. 40 weeks or more by date or 1st trimestric ultrasound. Bishop score of 4 or greater. Longitudinal lie. Vertex presentation. Intact membranes

Exclusion criteria:

Refused consent Malpresentation. Multiple pregnancies. Active phase of labour. Rupture of membranes (ROM). Cephalo-pelvic disproportion. Previous C-section or myomectomy operation. Known contraindication or hypersensitivity to Dexamethasone. Fetal distress. IUFD Current maternal disorder e.g. diabetes mellitus and pregnancy induced hypertension.

Over distended abdomen e.g. fetal macrosomia or polyhydramonus suggested by ultrasound.

Ante-partum hemorrhage e.g. placenta previa, accidental hemorrhage.

These criteria will be assessed at first during the initial evaluation in the delivery suite as follows:

History:

Personal, menstrual, obstetric, past and family history will be taken. History of present pregnancy will be taken including the first day of last menstrual period, duration of pregnancy, warning symptoms as headache, visual symptoms, edema of face and fingers, excessive vomiting, heart burn, epigastric pain, vaginal bleeding, decreased fetal movements, edema of the lower limbs and history of any drug intake.

Examination:

  1. General examination:vital signs, chest, heart and lower limb examination.
  2. Abdominal examination: for assessment of fundal level, presentation, expected fetal weight, fetal heart rate and presence of scars of previous operations as cesarean section or myomectomy.
  3. Vaginal examination: for assessment of cervical dilatation and effacement at the beginning, state of fetal membranes, station of fetal head, position of fetal head and pelvic adequacy.

Investigations:

  1. Laboratory: blood grouping, Rh typing, complete blood count.
  2. Abdominal ultrasound: to confirm the gestational age, fetal number, viability, presentation, position, estimated fetal weight, and to detect the grade of placental maturity, amount and turbidity of liquor.
  3. CTG: application of CTG half an hour to all participates before starting any intervention.

Enrollment and Allocation of the patients:

After approval of health ethical committee in Ain Shams Hospital and after the initial evaluation, women who fulfilled the appropriate inclusion and exclusion criteria will be invited to participate in the study, a verbal consent will be obtained from each candidate after explanation of the procedure in details.

Randomization:

The eligible 102 women will be randomized into one of the following two groups:

  1. Group D (study group): including 51 women who will receive a prefilled syringe with two milliliters (8 mg) of dexamethasone intravenously.
  2. Group P (control group): including 51 women who will receive a prefilled syringe with two milliliters of distilled water intravenously.

No cervical ripping agent will be used for induction of labor in either group. Randomization is performed using a computer-generated randomization system. 102 opaque envelopes will be numbered serially; each envelope will contain the corresponding letter in the randomization table, and when the first pregnant woman arrived, the first envelope will be opened and the pregnant woman will be allocated to the group according to the inside letter.

Being tested
Dexamethasone, Distilled Water

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DexamethasoneDrug

    Also called Drug group

    a prefilled syringe with two milliliters (8 mg) of dexamethasone intravenously

  • Distilled WaterDrug

    Also called Placebo group

    a prefilled syringe with two milliliters of distilled water intravenously.

Study groups in NCT03658590
Study groupRoleWhat they receive
Group DActive comparatorincluding 51 women who will receive a prefilled syringe with two milliliters (8 mg) of dexamethasone intravenously.
Receives: Drug: Dexamethasone
Group PPlacebo comparatorincluding 51 women who will receive a prefilled syringe with two milliliters of distilled water intravenously.
Receives: Drug: Distilled Water

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The interval between the initiation of induction and the delivery of the fetus.

    Mean time of interval between the initiation of induction and the delivery of the fetus in the two groups.

    Measured: Up to 1 day

Secondary outcomes (5)
  1. The duration of the first stage of labor (Partographic representation will do for each participant).

    Mean time of duration of the first stage of labor in the two groups.

    Measured: Up to 1 hour

  2. The duration of the second stage of labor.

    Mean time of duration of the second stage of labor in the two groups.

    Measured: Up to 2 hours

  3. The duration of the third stage of labor.

    Mean time of duration of the third stage of labor in the two groups.

    Measured: Up to 30 minutes

  4. The neonatal outcome by APGAR score.

    Mean of APGAR score at 1 and 5 minutes for fetus in the two groups.

    Measured: at 1 and 5 minutes

  5. Any postpartum maternal adverse effects (e.g. vital sing abnormality, any maternal postpartum hemorrhage and central nervous system manifestation).

    Percentage of postpartum adverse effects in both group.

    Measured: Up to 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2018
  2. Study start1 Jan 2018
  3. Primary completion15 Apr 2018
  4. Study completion30 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03658590
Sponsor's protocol ID
100
Status last verified
Sep 2018
First submitted
29 Aug 2018
Last updated
5 Sep 2018
Results posted
No
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Dexamethasone and Distilled Water in people with Induction of Labor Affected Fetus / Newborn, run by samar sayed el sayed at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The interval between the initiation of induction and the delivery of the fetus. (time frame: Up to 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in